1. An activated polymer composition comprising a molecularly self-assembling material and one or more active agents, wherein each active agent independently comprises an odor control material, polyelectrolyte, chelating agent, microspheres, non-peptidic antimicrobial substance, an anti-clotting compound, a clotting compound, or a wound healing promoter.
2. An activated polymer composition of claim 1, wherein the molecularly self-assembling material is selected from the group consisting of a polyester-amide, polyether-amide, polyester-urethane, polyether-urethane, polyether-urea, polyester-urea, or a mixture thereof.
3. An activated polymer composition of claim 1, wherein the molecularly self-assembling material comprises self-assembling units comprising multiple hydrogen bonding arrays.
4. (canceled)
5. (canceled)
6. (canceled)
7. An activated polymer composition of claim 1, wherein the molecularly self-assembling material comprises repeat units of formula I:
and at least one second repeat unit selected from the ester-amide units of Formula II and III:
and the ester-urethane units of Formula IV:
or combinations thereof wherein:
R is at each occurrence, independently a C2-C20 non-aromatic hydrocarbylene group, a C2-C20 non-aromatic heterohydrocarbylene group, or a polyalkylene oxide group having a group molecular weight of from about 100 grams per mole to about 5000 grams per mole;
R1 at each occurrence independently is a bond or a C1-C20 non-aromatic hydrocarbylene group;
R2 at each occurrence independently is a C1-C20 non-aromatic hydrocarbylene group;
RN is \u2014N(R3)\u2014Ra\u2014N(R3)\u2014, where R3 at each occurrence independently is H or a C1-C6 alkylene and Ra is a C2-C20 non-aromatic hydrocarbylene group, or RN is a C2-C20 heterocycloalkyl group containing the two nitrogen atoms, wherein each nitrogen atom is bonded to a carbonyl group according to formula (III) above;
n is at least 1 and has a mean value less than 2; and
w represents the ester mol fraction of Formula I, and x, y and z represent the amide or urethane mole fractions of Formulas II, III, and IV, respectively, where w+x+y+z=1, and 0<w<1, and at least one of x, y and z is greater than zero but less than 1.
8. An activated polymer composition of claim 1, wherein the molecularly self-assembling material is a polymer or oligomer of Formula II or III:
wherein
R is at each occurrence, independently a C2-C20 non-aromatic hydrocarbylene group, a C2-C20 non-aromatic heterohydrocarbylene group, or a polyalkylene oxide group having a group molecular weight of from about 100 grams per mole to about 5000 grams per mole;
R1 at each occurrence independently is a bond or a C1-C20 non-aromatic hydrocarbylene group;
R2 at each occurrence independently is a C1-C20 non-aromatic hydrocarbylene group;
RN is \u2014N(R3)\u2014Ra\u2014N(R3)\u2014, where R3 at each occurrence independently is H or a C1-C6 alkylene and Ra is a C2-C20 non-aromatic hydrocarbylene group, or RN is a C2-C20 heterocycloalkyl group containing the two nitrogen atoms, wherein each nitrogen atom is bonded to a carbonyl group according to formula (III) above;
n is at least 1 and has a mean value less than 2; and
x and y represent mole fraction wherein x+y=1, and 0\u2266x\u22661, and 0\u2266y\u22661.
9. An activated polymer composition of claim 1, wherein the number average molecular weight (Mn) of the molecularly self-assembling material is between about 1000 grams per mole (gmol) and about 50,000 gmol, inclusive.
10. An activated polymer composition of claim 9, wherein the Mn of the molecularly self-assembling material is less than 5,000 gmol.
11. An activated polymer composition of claim 1, wherein each active agent independently comprises the odor control material.
12. (canceled)
13. An activated polymer composition of claim 1, wherein each active agent independently comprises the non-peptidic antimicrobial substance, anti-clotting compound, clotting compound, or wound healing promoter.
14. (canceled)
15. (canceled)
16. (canceled)
17. (canceled)
18. An activated polymer composition of claim 1, wherein the one or more active agents comprises a total of from 0.0001 weight percent (wt %) to 75 wt % of the activated polymer composition based on total weight of the activated polymer composition.
19. An activated fiber comprising a fiber of a molecularly self-assembling material and one or more active agents, wherein each active agent independently comprises an odor control material, polyelectrolyte, chelating agent, microspheres, non-peptidic antimicrobial substance, an anti-clotting compound, a clotting compound, or a wound healing promoter.
20. (canceled)
21. (canceled)
22. An activated fiber of claim 19, the activated fiber comprising a woven or nonwoven web.
23. An activated-fiber composite comprising an activated fiber of claim 19 and a fiberweb support, wherein the fiberweb support is in supporting operative contact with the activated fiber.
24. A process for fabricating an activated fiber, the process comprising the steps of: elongating under fiber-forming conditions either a melt comprising a molecularly self-assembling material or a solution comprising a solvent and the molecularly self-assembling material; and contacting one or more active agents to the molecularly self-assembling material to produce the activated fiber of claim 19.
25. (canceled)
26. (canceled)
27. (canceled)
28. A process for making an activated-fiber composite, the process comprising the steps of: elongating under fiber-forming conditions either a melt comprising a molecularly self-assembling material or a solution comprising a solvent and the molecularly self-assembling material; contacting one or more active agents to the molecularly self-assembling material to produce an activated fiber; and operatively contacting the activated fiber to a fiberweb support to make the activated-fiber composite of claim 23.
29. (canceled)
30. An article comprising the activated polymer composition of claim 1.
31. (canceled)
32. (canceled)
33. An article of claim 30, wherein the article comprises a co-woven fabric comprising one or more non-(molecularly self-assembling) fibers and one or more activated fibers comprising a fiber of a molecularly self-assembling material and one or more active agents, wherein each active agent independently comprises an odor control material, polyelectrolyte, chelating agent, microspheres, non-peptidic antimicrobial substance, an anti-clotting compound, a clotting compound, or a wound healing promoter, the one or more activated fibers and the one or more non-(molecularly self-assembling) fibers being co-woven to provide the co-woven fabric.
34. A highly filled polymer filler composite comprising a molecularly self-assembling material and a mineral filler or conductive filler dispersed in the molecularly self-assembling material, wherein the mineral filler comprises a finely divided metal, metal carbonate, metal oxide, silica, or talc; the conductive filler comprises an activated carbon, carbon black, carbon nanotube, or fullerene and the conductive filler is in the form of a particle having an average size of 30 micrometers or smaller; the mineral filler or conductive filler comprising from 76 weight percent (wt %) to 90 wt % of the highly filled polymer filler composite based on total weight of the highly filled polymer filler composite the mineral filler being in the form of a particle having an average size of 1.0 micrometer or larger or a fiber having an average diameter of 1.0 micrometer or larger.
35. (canceled)
36. A process for making the highly filled polymer filler composite of claim 34, the process comprising the step of: dispersing a highly filling amount of the mineral filler or conductive filler in either a melt comprising the molecularly self-assembling material or a solution comprising a solvent and the molecularly self-assembling material to produce the highly filled polymer filler composite.
37. An article comprising the highly filled polymer filler composite of claim 34.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
I claim:
1. A compound of general formula (I)
RniYin(I),
wherein R is a group of general formula (A):
14
wherein
R1 and R3 are independently selected from the substituted and unsubstituted group consisting of C1-C10-alkyl, C3-C6-cycloalkyl, C3-C6-cycloalkenyl, C2-C10-alkenyl, C6-C14-aryl and a heterocycle, and hydrogen;
R2 is selected from the substituted and unsubstituted group consisting of C1-C6-alkylene, C3-C6-cycloalkylene, C3-C6-cycloalkenylene, C2-C6-alkenylene, C6-C14-arylene and a heterocycle;
R1 and R2 andor R2 and R3 can form an heterocycle optionally containing further nitrogen atoms;
Y is a physiologically compatible anion;
i and n are independently natural numbers 1, and
physiologically compatible addition salts,
provided that R is not:
15
16
and that if Y is NO3R is not
17
and
that if Y is NO3, CIO4 or CI, R is not
18
2. The compound according to claim 1, wherein Y in general formula (I) is SCN.
3. A medicament, containing a compound of general formula (I)
RniYin(I),
wherein R is a group of the general formula (A)
19
wherein
R1 and R3 are independently selected from the substituted and unsubstituted group consisting of C1-C10-alkyl, C3-C6-cycloalkyl, C3-C6-cycloalkenyl, C2-C10-alkenyl, C6-C14-aryl and a heterocycle, and hydrogen;
R2 is selected from the substituted and unsubstituted group consisting of C1-C6-alkylene, C3-C6-cycloalkylene, C3-C6-cycloalkenylene, C2-C6-alkenylene, C6-C14-arylene and a heterocycle;
R1 and R2 andor R2 and R3 can form an heterocycle optionally containing further nitrogen atoms;
Y is a physiologically compatible anion;
i and n are independently natural numbers 1, and
physiologically compatible addition salts.
4. The medicament according to claim 3, wherein R in general formula (I) is:
20
5. The medicament according to claim 3, wherein R in general formula (I) is:
21
6. A method of preventing or treating cancer diseases comprising using a compound of general formula (I) according to claim 1.